title: An evidence-based review of insomnia treatment in early recovery.
abstract: Accruing evidence indicates that insomnia is prevalent and persistent in early recovery from substance use disorders and may predict relapse. As such, insomnia treatment after abstinence represents an important area for intervention. This article reviews the literature on insomnia predicting new-onset alcohol and substance use disorders, along with evidence for insomnia predicting relapse in recovering populations. Pharmacological and psychological treatment options are presented, and cognitive-behavioral therapy for insomnia applied to recovering populations is described in detail.
authors.affiliation: From the Department of Psychiatry (KAK), Stanford University School of Medicine, Stanford, CA; Department of Psychiatry (JM, NR), University of California, San Francisco; and San Francisco VA Medical Center (JM, CP, NR), San Francisco, CA.
authors.forename: Katherine A
authors.initials: KA
authors.lastname: Kaplan
authors.forename: John
authors.initials: J
authors.lastname: McQuaid
authors.forename: Charles
authors.initials: C
authors.lastname: Primich
authors.forename: Nicholas
authors.initials: N
authors.lastname: Rosenlicht
mesh_terms: D015928:Cognitive Behavioral Therapy; D019317:Evidence-Based Medicine; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D012008:Recurrence; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D019966:Substance-Related Disorders / Q000150:complications / Q000628:therapy*
chemical_list: D006993:Hypnotics and Sedatives